Livongo Health, a digital health company targeting patients with chronic conditions, raised $105 million in a funding round led by General Catalyst and Kinnevik, the company said April 11.
The company will use the new funds to support market growth, continued investment in data science, deeper integration with clients and partners, and develop a comprehensive consumer platform based on the Livongo's "whole person" approach, which it defines as considering each member's physical, social and emotional needs.
Livongo also entered into a strategic partnership with Portland, Ore.-based Cambia Health Solutions to improve its members' health, starting with diabetes management.
"The strategic relationship announced with Cambia today is indicative of the type of partnership Livongo attracts — defining of a new era in health. We are delighted to expand our investment in Livongo. We believe they are on track to be the global leader in delivering real behavioral insights and science that enable people to truly live in healthier ways," said Kinnevik's Senior Investment Director Chris Bischoff, who is joining Livongo's board of directors.
More articles on health IT:
Registration employee at West Kendall Baptist Hospital misused patients' credit card information
Report: 94% of IT pros concerned about moving to the cloud — 4 survey insights
Healthcare — The only industry where insider threats outnumber external threats